LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | L13 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 5.36 | 27.76 | 832 | 320 | 2.5971 | 1.6212 | MN20160318_Q01 | L13 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 7.06 | 27.76 | 5 | 360 | 0.0139 | -0.3710 | MN20160318_Q01 | L11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 7.06 | 27.76 | 898 | 360 | 2.4944 | 1.5610 | MN20160318_Q01 | L11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | L13 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 7.06 | 27.76 | 854 | 360 | 2.3722 | 1.5264 | MN20160318_Q01 | L13 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 8.76 | 27.76 | 8 | 401 | 0.0199 | -0.2759 | MN20160318_Q01 | L11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 8.76 | 27.76 | 948 | 401 | 2.3632 | 1.5002 | MN20160318_Q01 | L11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 8.76 | 27.76 | 2 | 401 | 0.0050 | -0.4947 | MN20160318_Q01 | L13 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 8.76 | 27.76 | 923 | 401 | 2.3009 | 1.4829 | MN20160318_Q01 | L13 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 10.46 | 27.76 | 96 | 438 | 0.2189 | 0.3656 | MN20160318_Q01 | L11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 10.46 | 27.76 | 1020 | 438 | 2.3254 | 1.4721 | MN20160318_Q01 | L11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 10.46 | 27.76 | 4 | 438 | 0.0091 | -0.3852 | MN20160318_Q01 | L13 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 10.46 | 27.76 | 1013 | 438 | 2.3094 | 1.4678 | MN20160318_Q01 | L13 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 12.17 | 27.76 | 434 | 489 | 0.8874 | 0.9431 | MN20160318_Q01 | L11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 12.17 | 27.76 | 1086 | 489 | 2.2205 | 1.4251 | MN20160318_Q01 | L11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 12.17 | 27.76 | 6 | 489 | 0.0123 | -0.3093 | MN20160318_Q01 | L13 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 12.17 | 27.76 | 979 | 489 | 2.0018 | 1.3651 | MN20160318_Q01 | L13 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 13.87 | 27.76 | 833 | 604 | 1.3775 | 1.1494 | MN20160318_Q01 | L11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 13.87 | 27.76 | 1137 | 604 | 1.8802 | 1.3052 | MN20160318_Q01 | L11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 13.87 | 27.76 | 8 | 604 | 0.0132 | -0.2441 | MN20160318_Q01 | L13 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 13.87 | 27.76 | 1073 | 604 | 1.7744 | 1.2754 | MN20160318_Q01 | L13 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 15.58 | 27.76 | 929 | 685 | 1.3551 | 1.1358 | MN20160318_Q01 | L11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 15.58 | 27.76 | 1086 | 685 | 1.5841 | 1.2091 | MN20160318_Q01 | L11 |
MCF 10A-H2B-mCherry | Neratinib | 0.56234 | 15.58 | 27.76 | 8 | 685 | 0.0117 | -0.2358 | MN20160318_Q01 | L13 |